133 related articles for article (PubMed ID: 37545790)
1. External validation of
Tjong MC; Zhang SC; Gasho JO; Silos KD; Gay C; McKenzie EM; Steers J; Bitterman DS; Nikolova AP; Nohria A; Hoffmann U; Brantley KD; Mak RH; Atkins KM
Clin Transl Radiat Oncol; 2023 Sep; 42():100660. PubMed ID: 37545790
[TBL] [Abstract][Full Text] [Related]
2. Major adverse cardiac event risk prediction model incorporating baseline Cardiac disease, Hypertension, and Logarithmic Left anterior descending coronary artery radiation dose in lung cancer (CHyLL).
Tjong MC; Bitterman DS; Brantley K; Nohria A; Hoffmann U; Atkins KM; Mak RH
Radiother Oncol; 2022 Apr; 169():105-113. PubMed ID: 35182687
[TBL] [Abstract][Full Text] [Related]
3. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.
Atkins KM; Chaunzwa TL; Lamba N; Bitterman DS; Rawal B; Bredfeldt J; Williams CL; Kozono DE; Baldini EH; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JAMA Oncol; 2021 Feb; 7(2):206-219. PubMed ID: 33331883
[TBL] [Abstract][Full Text] [Related]
4. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.
Atkins KM; Bitterman DS; Chaunzwa TL; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1473-1479. PubMed ID: 33713743
[TBL] [Abstract][Full Text] [Related]
5. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
6. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
[TBL] [Abstract][Full Text] [Related]
7. Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
No HJ; Guo FB; Park NJ; Kastelowitz N; Rhee JW; Clark DE; Chin AL; Vitzthum LK; Horst KC; Moding EJ; Loo BW; Diehn M; Binkley MS
JACC CardioOncol; 2023 Dec; 5(6):775-787. PubMed ID: 38205000
[TBL] [Abstract][Full Text] [Related]
8. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
9. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
[TBL] [Abstract][Full Text] [Related]
10. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
11. [Value of fractional flow reserve derived from coronary computed tomographic angiography and plaque quantitative analysis in predicting adverse outcomes of non-obstructive coronary heart disease].
Liu J; Wu Y; Huang H; Wang P; Wu Q; Qiao H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):615-619. PubMed ID: 37366128
[TBL] [Abstract][Full Text] [Related]
12. Does coronary artery calcium score have an impact on overall survival for locally advanced non-small cell lung cancer treated with definitive radiotherapy.
Olloni A; Brink C; Lorenzen EL; Jeppesen SS; Hoffmann L; Kristiansen C; Knap MM; Møller DS; Nygård L; Persson GF; Thing RS; Sand HM; Diederichsen A; Schytte T
Radiother Oncol; 2023 Aug; 185():109719. PubMed ID: 37257588
[TBL] [Abstract][Full Text] [Related]
13. Cardiac Toxicity After Radiotherapy for Stage III Non-Small-Cell Lung Cancer: Pooled Analysis of Dose-Escalation Trials Delivering 70 to 90 Gy.
Wang K; Eblan MJ; Deal AM; Lipner M; Zagar TM; Wang Y; Mavroidis P; Lee CB; Jensen BC; Rosenman JG; Socinski MA; Stinchcombe TE; Marks LB
J Clin Oncol; 2017 May; 35(13):1387-1394. PubMed ID: 28113017
[TBL] [Abstract][Full Text] [Related]
14. Machine learning derived ECG risk score improves cardiovascular risk assessment in conjunction with coronary artery calcium scoring.
Siva Kumar S; Al-Kindi S; Tashtish N; Rajagopalan V; Fu P; Rajagopalan S; Madabhushi A
Front Cardiovasc Med; 2022; 9():976769. PubMed ID: 36277775
[TBL] [Abstract][Full Text] [Related]
15. Fractal Analysis of Left Ventricular Trabeculae in Patients with End-Stage Renal Disease: A Random Survival Tree Analysis.
Zhang TY; An DA; Yan H; Wang J; Zhou H; Chen B; Lu R; Fang W; Wang Q; Che X; Huang J; Jin H; Shen J; Zhou Y; Mou S; Chen J; Fang Y; Wu LM
J Magn Reson Imaging; 2024 Jan; ():. PubMed ID: 38270242
[TBL] [Abstract][Full Text] [Related]
16. The Value of the Systemic Immune-Inflammation Index in Predicting Survival Outcomes in Patients with Brain Metastases of Non-Small-Cell Lung Cancer Treated with Stereotactic Radiotherapy.
Zhang Y; Chen Z; Jin F; Guo D; Chen Q; Liu Z; Ji S; Gao G
Mediators Inflamm; 2021; 2021():2910892. PubMed ID: 34744510
[TBL] [Abstract][Full Text] [Related]
17. Left Atrial Function with MRI Enables Prediction of Cardiovascular Events after Myocardial Infarction: Insights from the AIDA STEMI and TATORT NSTEMI Trials.
Schuster A; Backhaus SJ; Stiermaier T; Navarra JL; Uhlig J; Rommel KP; Koschalka A; Kowallick JT; Lotz J; Gutberlet M; Bigalke B; Kutty S; Hasenfuss G; Thiele H; Eitel I
Radiology; 2019 Nov; 293(2):292-302. PubMed ID: 31526253
[TBL] [Abstract][Full Text] [Related]
18. Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer.
Atkins KM; Bitterman DS; Chaunzwa TL; Williams CL; Rahman R; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Pract Radiat Oncol; 2021; 11(5):e459-e467. PubMed ID: 33476841
[TBL] [Abstract][Full Text] [Related]
19. Relationship between major adverse cardiac events and angiographic findings in dialysis patients.
Fabbian F; Cacici G; De Biase V; Yabarek T; Gangemi C; Franceschini L; De Giorgi A; Benussi P; Lupo A; Portaluppi F
Int Urol Nephrol; 2011 Dec; 43(4):1171-8. PubMed ID: 20811775
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Coronary Artery Bypass Graft SYNTAX Score (Synergy Between Percutaneous Coronary Intervention With Taxus) as a Prognostic Marker for Patients With Previous Coronary Artery Bypass Graft Surgery After Percutaneous Coronary Intervention.
Miyagi T; Asaumi Y; Nishimura K; Nakashima T; Sakamoto H; Nakao K; Kanaya T; Nagai T; Shimabukuro Y; Miyamoto Y; Fujita T; Kusano K; Anzai T; Kobayashi J; Noguchi T; Ogawa H; Yasuda S
Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27578838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
